TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval.

S B Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.